ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO738

Infertility and Pregnancy Loss in Hispanic/Latino Women with CKD: Results from the Hispanic Community Health Study/ Study of Latinos (HCHS/SOL)

Session Information

Category: Women’s Health and Kidney Diseases

  • 2000 Women’s Health and Kidney Diseases

Authors

  • Reynolds, Monica Lona, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Loehr, Laura R., University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Hogan, Susan L., University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Hu, Yichun, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Isasi, Carmen, Albert Einstein College of Medicine, Bronx, New York, United States
  • Cordero, Christina, University of Miami, Miami, Florida, United States
  • Ricardo, Ana C., University of Illinois at Chicago, Chicago, Illinois, United States
  • Lash, James P., University of Illinois at Chicago, Chicago, Illinois, United States
  • Derebail, Vimal K., University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Background

Hispanic/Latino individuals are less likely to be screened or receive optimal CKD treatment. This may be particularly detrimental for reproductive age women as CKD has been associated with infertility, menstrual irregularities, and pregnancy loss.

Methods

Using data from the HCHS/SOL baseline (2008-2011) and second study visits (2014-2017), we assessed CKD and self-reported infertility, cessation of menses, and nonviable pregnancy loss (<24 weeks gestation) in women age 18-45 years old. CKD was defined as one of the following at both study visits: albuminuria (urine albumin:creatinine [UACR] >30 mg/g) or an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2. To capture mild CKD and variation in visit measurements, we also included those with UACR >300 mg/g at any visit, eGFR <60 mL/min/1.73m2at one visit and <70 mL/min/1.73m2 at the other, or if baseline UACR >30 mg/g while on RAAS-blockade. Survey-specific analyses were used to account for the two-stage probability sampling design. Multivariable survey logistic regression derived prevalence odds ratios (OR) with 95% confidence intervals for our outcomes of interest. Using a 10% change-in-estimate approach, covariates considered were age, body mass index (BMI), hypertension (HTN) and diabetes (DM).

Results

Of 2,589 included, 4.6% had CKD. Women with CKD were older (41 vs 38), had a higher BMI (34 kg/m2 vs 30 kg/m2), and more DM (32% vs 11%) and HTN (42% vs 12%). In adjusted analysis, those with CKD did not have a significantly increased odds of infertility, cessation of menses, or nonviable loss (see table). Among 635 women with pregnancies occurring specifically between baseline and second visit, the OR of nonviable loss with CKD was 1.7 (95% CI 0.5-5.8) but not statistically significant.

Conclusion

In this Hispanic/Latino cohort, CKD was uncommon and not associated with our outcomes of interest but our sample size limited statistical power. Considering the temporality of CKD diagnosis and pregnancy in a larger sample warrants further study.

 InfertilityCessation of MensesHistory of Nonviable Loss (total N= 2277, no CKD N= 2167, CKD N= 112)
Characteristic NUnadjusted OR (95% CI)Adjusted* OR (95% CI)Unadjusted OR (95% CI)Adjusted^ OR (95% CI)Unadjusted OR (95% CI)Adjusted^ OR (95% CI)
No CKD2469ReferenceReferenceReferenceReferenceReferenceReference
CKD1201.20 (0.49-2.95)1.08 (0.42-2.75)2.15 (1.15-4.00)1.30 (0.52-3.27)0.82 (0.50-1.33)0.78 (0.47-1.29)

*Adjusted for presence of DM ^Adjusted for age